证券记录 · 已归档季度
AZN
AstraZeneca PLC · Healthcare · Drug Manufacturers - General
21被追踪持有人
+3Δ持有人
174.28M持有股份
$11.42B报告持仓市值
+3新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +16.7% ·
股份流向 +4.0% ·
净新建仓位 +14.3%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 6 | 0 | 6.13M | $989.29M | n/a | n/a |
| Q2 2026 | 156 | +6 | 601.40M | $113.10B | +11 | −4 |
| Q1 2026 | 151 | +2 | 571.10M | $111.81B | +21 | −20 |
| Q4 2025 | 148 | 0 | 438.95M | $40.35B | +2 | −1 |
| Q3 2025 | 24 | 0 | 219.30M | $16.82B | +1 | −2 |
| Q2 2025 | 22 | -1 | 189.68M | $13.26B | n/a | −1 |
| Q1 2025 | 21 | 0 | 171.06M | $12.57B | n/a | n/a |
| Q4 2024 | 21 | +3 | 174.28M | $11.42B | +3 | n/a |
| Q3 2024 | 17 | -3 | 166.39M | $12.97B | n/a | −3 |
| Q2 2024 | 20 | n/a | 172.48M | $13.45B | n/a | n/a |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 60.35M | -4.0% | $3.95B | 0.5% | ▼ Trim | 3 | SEC ↗ ×2 |
| 2 | PRIMECAP Management ✦ | 41.02M | -2.3% | $2.69B | 2.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 37.04M | -0.6% | $2.43B | 0.4% | ▼ Trim | 3 | SEC ↗ ×8 |
| 4 | Fisher Asset Management ✦ | 10.96M | +4.6% | $718.09M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 4.83M | +203.3% | $316.22M | 0.4% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 4.22M | +841.6% | $276.68M | 0.3% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 3.88M | 新增 | $254.02M | 0.3% | New | 1 | SEC ↗ ×3 |
| 8 | Soros Fund Management ✦ | 3.16M | +19.0% | $206.77M | 5.2% | ▲ Add | 3 | SEC ↗ |
| 9 | Millennium Management ✦ | 2.90M | +2346.0% | $189.87M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (被动) | 1.20M | n/a | $78.61M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 1.12M | +236.1% | $73.19M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 1.07M | 新增 | $70.34M | 0.2% | New | 1 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 673.46K | +228.3% | $44.13M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 661.67K | -39.8% | $43.35M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | Geode Capital Management ✦ (被动) | 498.83K | +1.1% | $32.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 353.44K | 新增 | $23.16M | 0.0% | New | 1 | SEC ↗ |
| 17 | Dodge & Cox ✦ | 143.71K | -3.6% | $9.42M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Capital World Investors ✦ | 143.03K | -97.7% | $9.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 25.81K | +36.8% | $1.69M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 20 | Renaissance Technologies ✦ | 20.37K | -93.3% | $1.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Norges Bank ✦ (被动) | 16.38K | -86.4% | $1.07M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $254.02M | 0.3% |
| Point72 Asset Management | $70.34M | 0.2% |
| Adage Capital Partners | $23.16M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,307 持有人, 729.50M 股份, $139.69B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 08
Sharma Mani
Officer · See Remarks · 20 股 @ 160.57 · $3,249
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据